Identification of Jam-A As a Vulnerable Plaque Marker and Its Implication in Ultrasound-Based Plaque Stability Assessment

Yajun Zhang,Yunyou Duan,Lijun Yuan,Danna Bai,Liang Jin,Jingxi Du,Jing Ma,Wenbin Cai,Yang Feng,Changyang Xing
DOI: https://doi.org/10.1016/j.ultrasmedbio.2017.08.956
IF: 3.694
2017-01-01
Ultrasound in Medicine & Biology
Abstract:Identification of vulnerable atherosclerotic plaques by imaging the molecular characteristics is intensively studied recently. In this study, we aimed to identify novel markers for vulnerable plaques and then develop targeted ultrasound microbubbles for plaque stability assessment. Vulnerable and stable plaques were created in rabbits with high cholesterol diet with or without partial ligation of carotid artery respectively. Expression of Junctional Adhesion Molecule –A (JAM-A ) at mRNA and protein levels between vulnerable and stable plaques were compared by qPCR and Western blot. JAM-A antibody conjugated microbubbles (MBJAM-A) or control IgG-conjugated microbubbles (MBC) were developed by conjugating the biotinylated antibodies to the streptavidin modified microbubbles, and visualized by contrast-enhance ultrasound (CEUS). Significant higher JAM-A expression was found in vulnerable plaques than that in stable plaques. Furthermore, JAM-A was not only expressed in the endothelium, but also abundantly expressed in CD68-positive area. Signal intensity of MBJAM-A was substantially enhanced and prolonged in the vulnerable plaque and some of the MBJAM-A was found colocalized with CD68 positive macrophages. In vitro cell model revealed that some MBJAM-A were able to be phagocytized by activated macrophages. Our study has found that increase of JAM-A serves as a marker for vulnerable plaques and targeted CEUS would be possibly a novel non-invasive molecular imaging method for plaque vulnerability.
What problem does this paper attempt to address?